Arranon and hypoaesthesia Patient Reports February 10, 2010

Arranon Side Effects Report #5961041-6
Arranon side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2008. Female patient, 42 years of age, was treated with Arranon. After drug was administered, patient experienced the following side effects: hypoaesthesia, neuropathy peripheral. Arranon dosage: 1500MGM2 VARIABLE DOSE. During the same period patient was treated with METHOTREXATE, CYTARABINE, HYDROCORTISONE, LEVOFLOXACIN. Patient recovered.

Arranon Side Effects Report #5210665-2
Arranon side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2007. Female patient, 21 years of age, was treated with Arranon. After drug was administered, patient experienced the following side effects: gait disturbance, hypoaesthesia, monoplegia, muscular weakness, neuropathy, peripheral sensory neuropathy, sensory loss. Arranon dosage: 1500MG ALTERNATE DAYS. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, VANCOMYCIN. Patient was hospitalized and became disabled. Patient recovered.

Arranon Side Effects Report #5811727-9
Arranon side effect was reported by a Physician from JAPAN on July 11, 2008. Male patient, 19 years of age, weighting 110.2 lb, was diagnosed with neoplasm malignant and was treated with Arranon. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, febrile neutropenia, hyperbilirubinaemia, hypoaesthesia, muscular weakness, platelet count decreased, stomatitis. Arranon dosage: 1500MG PER DAY. During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE, ETOPOSIDE, CYTARABINE, METHOTREXATE, CYLOCIDE, ONCOVIN. Patient was hospitalized and became disabled. Patient recovered.

Arranon Side Effects Report #6126164-X
Arranon side effect was reported by a Physician from JAPAN on Mar 17, 2009. Male patient, 19 years of age, weighting 110.2 lb, was diagnosed with neoplasm malignant and was treated with Arranon. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, febrile neutropenia, hyperbilirubinaemia, hypoaesthesia, muscular weakness, platelet count decreased, stomatitis. Arranon dosage: 1500MG PER DAY. During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE, ETOPOSIDE, CYTARABINE, METHOTREXATE, CYLOCIDE, ONCOVIN. Patient was hospitalized and became disabled. Patient recovered.